VR Adviser, LLC - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 51 filers reported holding INOZYME PHARMA INC in Q1 2023. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.

Quarter-by-quarter ownership
VR Adviser, LLC ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q4 2022$2,845,486
-60.8%
2,709,9870.0%0.48%
-57.3%
Q3 2022$7,263,000
-43.8%
2,709,9870.0%1.12%
-56.0%
Q2 2022$12,927,0002,709,9872.55%
Other shareholders
INOZYME PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 4,494,851$18,878,3747.53%
CHI Advisors LLC 1,270,027$5,334,1122.11%
Samsara BioCapital, LLC 1,562,500$6,562,5002.01%
Affinity Asset Advisors, LLC 1,379,852$5,795,3781.63%
Sofinnova Investments, Inc. 4,280,308$17,977,2941.13%
SPHERA FUNDS MANAGEMENT LTD. 1,234,907$5,186,6090.94%
Octagon Capital Advisors LP 1,300,000$5,460,0000.84%
NEA Management Company, LLC 2,437,689$10,238,2940.79%
Knott David M Jr 454,008$1,9070.73%
Rock Springs Capital Management LP 3,681,174$15,460,9310.41%
View complete list of INOZYME PHARMA INC shareholders